コンテンツへスキップ
Merck

EQCYTMG-93KPX23

Millipore

MILLIPLEX® Equine Cytokine/Chemokine Magnetic Bead Panel Premixed 23-Plex Panel - Immunology Multiplex Assay

The Equine Inflammation / Immunology Bead-Based Multiplex Cytokine Assay kit, using the Luminex xMAP technology, enables the simultaneous analysis of 23 cytokine and chemokine biomarkers in equine serum, plasma and cell culture samples.

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12161503
eCl@ss:
32161000
NACRES:
NA.47

品質水準

化学種の反応性

horse

メーカー/製品名

Milliplex®

assay range

accuracy: 76%
(IL-6)

accuracy: 78%
(FGF-2)

accuracy: 82%
(G-CSF)

accuracy: 85%
(IL-13)

accuracy: 87%
(TNFα)

accuracy: 88%
(RANTES/CCL5)

accuracy: 90%
(IL-2)

accuracy: 92%
(GM-CSF)

accuracy: 94%
(IL-18)

accuracy: 97%
(GRO)

sensitivity: 1.4 pg/mL
(IL-6)

sensitivity: 10.6 pg/mL
(IL-5)

sensitivity: 13.5 pg/mL
(IL-2)

sensitivity: 15.4 pg/mL
(IL-17A)

sensitivity: 16.3 pg/mL
(FGF-2)

sensitivity: 16.7 pg/mL
(IP-10)

sensitivity: 165 pg/mL
(IFNγ)

sensitivity: 25.3 pg/mL
(IL-18)

sensitivity: 29.3 pg/mL
(IL-1β)

sensitivity: 3.9 pg/mL
(RANTES/CCL5)

sensitivity: 3.94 pg/mL
(GM-CSF)

sensitivity: 340 pg/mL
(G-CSF)

sensitivity: 355 pg/mL
(IL-4)

sensitivity: 39-130 pg/mL
(IL-13)

sensitivity: 39.1 pg/mL
(IL-1α)

sensitivity: 399 ng/mL
(MCP-1)

sensitivity: 457 pg/mL
(Fractalkine/CS3CL1)

sensitivity: 49.2 pg/mL
(IL-12 (p70))

sensitivity: 5.2 pg/mL
(TNFα)

sensitivity: 62.5 pg/mL
(IL-10)

sensitivity: 7.8 pg/mL
(GRO)

sensitivity: 74.3 pg/mL
(IL-8/CXCL8)

sensitivity: 8.3 pg/mL
(Eotaxin/CCL11)

standard curve range: 15-15,000 pg/mL
(IL-17A)

standard curve range: 15-15,000 pg/mL
(IL-2)

standard curve range: 15-15,000 pg/mL
(IL-5)

standard curve range: 15-15,000 pg/mL
(IL-6)

standard curve range: 15-15,000 pg/mL
(IP-10)

standard curve range: 24-25,000 pg/mL
(FGF-2)

standard curve range: 29-30,000 pg/mL
(IL-1β)

standard curve range: 293-300,000 pg/mL
(IL-4)

standard curve range: 34-35,000 pg/mL
(IL-18)

standard curve range: 342-350,000 ng/mL
(MCP-1)

standard curve range: 39-40,000 pg/mL
(IL-12 (p70))

standard curve range: 39-40,000 pg/mL
(IL-13)

standard curve range: 4-4,000 pg/mL
(TNFα)

standard curve range: 488-500,000 pg/mL
(IFNγ)

standard curve range: 49-50,000 pg/mL
(IL-10)

standard curve range: 5-5,000 pg/mL
(GM-CSF)

standard curve range: 5-5,000 pg/mL
(RANTES/CCL5)

standard curve range: 586-600,000 pg/mL
(Fractalkine/CS3CL1)

standard curve range: 59-60,000 pg/mL
(IL-1α)

standard curve range: 59-60,000 pg/mL
(IL-8/CXCL8)

standard curve range: 6-6,000 pg/mL
(GRO)

standard curve range: 7-7,000 pg/mL
(Eotaxin/CCL11)

standard curve range: 78-80,000 pg/mL
(G-CSF)

テクニック

multiplexing: suitable

適合性

configured for Premixed

検出方法

fluorometric (Luminex xMAP)

輸送温度

wet ice

詳細

Inflammation and immune cell response are key to maintaining homeostasis. The more we understand the mechanisms of disease, the more we discover the role that inflammation plays in the etiology of disease. This is as true for horses as it is for humans. Both experience immunological diseases, such as infectious diseases, osteoarthritis, and respiratory diseases, as well as neurologic, metabolic, and cardiovascular diseases and cancer. Until now the ability to measure levels of cytokines and chemokine in horses had been limited primarily to ELISAs. Researchers can now measure multiple inflammation biomarkers simultaneously using the MILLIPLEX® Equine Cytokine/Chemokine Panel, based on the Luminex® xMAP® technology.

MILLIPLEX® Equine Cytokine/Chemokine Premix Panel is a 23-plex kit used for the simultaneous quantification of all the following analytes in equine serum, plasma, or culture supernatant samples: Eotaxin/CCL11, FGF-2, Fractalkine/CS3CL1, G-CSF, GM-CSF, GRO, IFN, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8/CXCL8, IL-10, IL-12 (p70), IL-13, IL-17a, IL-18, IP-10, MCP-1, RANTES/CCL5 and TNFα. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Cytokines/Chemokines

アプリケーション

  • Analytes: Eotaxin/CCL11, FGF-2, Fractalkine/CX3CL1, G-CSF, GM-CSF, GRO/KC, IFN-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 (p70), IL-13, IL-17A, IL-18, IP-10 (CXCL10), MCP-1, RANTES (CCL5), TNF-α
  • Recommended Sample Type: Equine serum, plasma, tissue culture supernatant or tissue/cell extracts
  • Recommended Sample Dilution: 25 μL per well of undiluted serum or plasma; tissue/cell culture samples may require dilution with an appropriate medium
  • Assay Run Time: Overnight or One Day A primary incubation of 2 hours at room temperature (RT) (20-25°C), or for greater sensitivity, overnight (16-18 hours) at 2-8°C; followed by a 1 hour secondary incubation at RT
  • Research Category: Inflammation & Immunology

法的情報

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

ピクトグラム

Health hazardCorrosionExclamation markEnvironment

シグナルワード

Danger

危険有害性の分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

ターゲットの組織

Respiratory Tract

保管分類コード

10 - Combustible liquids


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

毒物及び劇物取締法

キットコンポーネントの情報を参照してください

PRTR

キットコンポーネントの情報を参照してください

消防法

キットコンポーネントの情報を参照してください

労働安全衛生法名称等を表示すべき危険物及び有害物

キットコンポーネントの情報を参照してください

労働安全衛生法名称等を通知すべき危険物及び有害物

キットコンポーネントの情報を参照してください

カルタヘナ法

キットコンポーネントの情報を参照してください

Jan Code

キットコンポーネントの情報を参照してください


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Hannah C Valigura et al.
Journal of animal science, 99(8) (2021-06-29)
Mitigation of exercise-induced stress is of key interest in determining ways to optimize performance horse health. To test the hypothesis that dietary supplementation of a Saccharomyces cerevisiae fermentation product would decrease markers of exercise-induced stress and inflammation in young horses

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)